**Core Concept**
Ezetimibe is a cholesterol absorption inhibitor that targets a specific step in the intestinal absorption of cholesterol. It works by inhibiting the Niemann-Pick C1-Like 1 (NPC1L1) protein, which is responsible for the uptake of cholesterol from the intestinal lumen into enterocytes.

**Why the Correct Answer is Right**
Ezetimibe binds to the NPC1L1 protein on the surface of enterocytes, preventing the uptake of cholesterol from the intestinal lumen. This results in a decrease in the amount of cholesterol that is absorbed into the bloodstream, leading to a reduction in circulating cholesterol levels. Ezetimibe does not affect the absorption of other nutrients, making it a targeted therapy for lowering cholesterol.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because ezetimibe does not work by inhibiting the absorption of dietary cholesterol through the formation of micelles (bile salts and cholesterol).
**Option B:** This option is incorrect because ezetimibe does not increase the excretion of bile acids, which is the mechanism of action of bile acid sequestrants.
**Option C:** This option is incorrect because ezetimibe does not inhibit the synthesis of cholesterol in the liver, which is the mechanism of action of statins.

**Clinical Pearl / High-Yield Fact**
Ezetimibe is often used in combination with statins to achieve greater reductions in circulating cholesterol levels. It is also used in patients who cannot tolerate statins or have a history of statin-induced myopathy.

**Correct Answer:** C.